At this Reuters Events session, in partnership with the European Federation of Pharmaceutical Industries & Associations (EFPIA), a panel of policymakers, regulators, and industry representatives will debate how to forge a future-proofed regulatory framework and why this will stimulate R&D and accelerate patient access across the Union. Among the speakers are representatives from the European Commission (DG SANTE) & the European Medicines Agency (EMA).

On the agenda:

· Why having a future-proof regulatory framework matters and how it could revolutionise the way we conduct     research & development of medicines.

· How the EU regulatory framework is performing compared to other regions: its strengths and areas for the greatest    potential improvement.

· Concrete solutions to make a world-leading Europe regulatory system, and the resources needed to deliver this.

More information and registration on the event website.